Stock Earnings
UroGen Pharma Ltd (URGN) may enjoy gains as insiders got busy in the recent days
UroGen Pharma Ltd’s filing revealed that its Chief Medical Officer Schoenberg Mark unloaded Company’s shares for reported $11236.0 on Sep
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.